Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-060551

Chief Executive Officer gave up 963 shares (to pay taxes)

  • Chief Executive Officer acquired 3,646 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Quart Barry D · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-13 Exercise or conversion : show line 1 in the form +3,646 103,049 D
2021-10-13 Shares withheld for taxes : show line 2 in the form −963 $10.55 $10,160 102,086 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-10-13 Exercise or conversion : show line 3 in the form Restricted Stock Units −3,646 43,750 D
2021-10-13 Grant or award : show line 4 in the form Employee Stock Option (Right to Buy) +390,834 390,834 D
2021-10-13 Grant or award : show line 5 in the form Restricted Stock Units +195,417 195,417 D
Loading xslF345X03/doc4.xml…